BioCentury | Nov 13, 2020
Emerging Company Profile

Kira: overcoming the complexities of complement

...Co. Ltd. (Shanghai:603259; HKEX:2359).The biotech, which has raised $46 million in venture capital from Quan Capital, 6 Dimensions Capital...
...PanUniversity collaborators: University of PennsylvaniaCorporate partners: UndisclosedNumber of employees: 23Funds raised: $46 millionInvestors: Quan Capital, 6 Dimensions Capital...
BioCentury | Jul 10, 2020
Finance

Trio of Hong Kong listings raise $865M

...range, valuing the company at HK$8.4 billion. Morgan Stanley, Goldman Sachs and UBS are underwriters. 6 Dimensions Capital...
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

...approvals in mainland China (see “Canbridge Raises $98M to Commercialize Products” ). Healthcare investment firm 6 Dimensions Capital...
...Inc. Robin Sawka, BioCentury Staff Radius Health Inc. Anika Therapeutics Inc. AMAG Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc. Forma Therapeutics Inc. Canbridge Pharmaceuticals Inc. 6 Dimensions Capital...
BioCentury | Apr 1, 2020
Finance

Reversing course on IPO plans, iTeos draws $125M in private round with crossovers

...Janus Henderson, RTW Investments and Invus. Also participating were existing investors MPM Capital, HBM Partners, 6 Dimensions Capital...
BioCentury | Jan 10, 2020
Financial News

Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas

...Institutes for BioMedical Research (NIBR), Pitango Venture Capital, and Astellas Venture Management and existing investors 6 Dimensions Capital...
BioCentury | Nov 14, 2019
Company News

Months after investment, Bayer strikes option deal with Dewpoint in CV, women’s health

...a partner at Polaris Partners, Dewpoint’s founding investor. Other series A investors include Samsara BioCapital, 6 Dimensions Capital...
BioCentury | Sep 23, 2019
Financial News

Fall IPO flurry as biotechs ramp up listing timelines

...unit in 2018 with a $250 million series A led by Chinese firm Boyu Capital, 6 Dimensions Capital...
BioCentury | Aug 29, 2019
Financial News

MedImmune-spinout Viela seeking $150M IPO

...NYSE:AZN) in 2018 with a $250 million series A led by Chinese firm Boyu Capital, 6 Dimensions Capital...
...shares. Boundless Meadow Ltd. is the next biggest shareholder ahead of the offering, with 18.4%; 6 Dimensions Capital...
BioCentury | Aug 22, 2019
Emerging Company Profile

Tscan: Tracking down novel T cell targets

...None Number of employees: 26 Funds raised: $55 million Investors: Novartis Institutes for BioMedical Research, 6 Dimensions Capital...
BioCentury | Jul 3, 2019
Emerging Company Profile

Kymera: a systematic approach to protein degradation

...Funds raised: $116 million Investors: Atlas Venture, Alexandria Real Estate Equities, Lilly Ventures, Amgen Ventures, 6 Dimensions Capital...
Items per page:
1 - 10 of 86
BioCentury | Nov 13, 2020
Emerging Company Profile

Kira: overcoming the complexities of complement

...Co. Ltd. (Shanghai:603259; HKEX:2359).The biotech, which has raised $46 million in venture capital from Quan Capital, 6 Dimensions Capital...
...PanUniversity collaborators: University of PennsylvaniaCorporate partners: UndisclosedNumber of employees: 23Funds raised: $46 millionInvestors: Quan Capital, 6 Dimensions Capital...
BioCentury | Jul 10, 2020
Finance

Trio of Hong Kong listings raise $865M

...range, valuing the company at HK$8.4 billion. Morgan Stanley, Goldman Sachs and UBS are underwriters. 6 Dimensions Capital...
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

...approvals in mainland China (see “Canbridge Raises $98M to Commercialize Products” ). Healthcare investment firm 6 Dimensions Capital...
...Inc. Robin Sawka, BioCentury Staff Radius Health Inc. Anika Therapeutics Inc. AMAG Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc. Forma Therapeutics Inc. Canbridge Pharmaceuticals Inc. 6 Dimensions Capital...
BioCentury | Apr 1, 2020
Finance

Reversing course on IPO plans, iTeos draws $125M in private round with crossovers

...Janus Henderson, RTW Investments and Invus. Also participating were existing investors MPM Capital, HBM Partners, 6 Dimensions Capital...
BioCentury | Jan 10, 2020
Financial News

Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas

...Institutes for BioMedical Research (NIBR), Pitango Venture Capital, and Astellas Venture Management and existing investors 6 Dimensions Capital...
BioCentury | Nov 14, 2019
Company News

Months after investment, Bayer strikes option deal with Dewpoint in CV, women’s health

...a partner at Polaris Partners, Dewpoint’s founding investor. Other series A investors include Samsara BioCapital, 6 Dimensions Capital...
BioCentury | Sep 23, 2019
Financial News

Fall IPO flurry as biotechs ramp up listing timelines

...unit in 2018 with a $250 million series A led by Chinese firm Boyu Capital, 6 Dimensions Capital...
BioCentury | Aug 29, 2019
Financial News

MedImmune-spinout Viela seeking $150M IPO

...NYSE:AZN) in 2018 with a $250 million series A led by Chinese firm Boyu Capital, 6 Dimensions Capital...
...shares. Boundless Meadow Ltd. is the next biggest shareholder ahead of the offering, with 18.4%; 6 Dimensions Capital...
BioCentury | Aug 22, 2019
Emerging Company Profile

Tscan: Tracking down novel T cell targets

...None Number of employees: 26 Funds raised: $55 million Investors: Novartis Institutes for BioMedical Research, 6 Dimensions Capital...
BioCentury | Jul 3, 2019
Emerging Company Profile

Kymera: a systematic approach to protein degradation

...Funds raised: $116 million Investors: Atlas Venture, Alexandria Real Estate Equities, Lilly Ventures, Amgen Ventures, 6 Dimensions Capital...
Items per page:
1 - 10 of 86